In the Jordan ruling, a five - judge majority of the Supreme Court said if a case in provincial court takes longer than 18 months between the person's arrest and
the anticipated end of their trial, then it should be stayed unless the Crown can prove there are exceptional circumstances.
Actual results and the timing
of events could differ materially from those
anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing
of, and risks relating to, the executive search process; risks related to the potential failure
of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical
trials and studies
of eptinezumab sufficient to achieve a positive completion; the availability
of data at the expected times; the clinical, therapeutic and commercial value
of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture
of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights
of others; the uncertain timing and level
of expenses associated with Alder's development and commercialization activities; the sufficiency
of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year
ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
On 6 May 2005, Withers wrote to MasterCigars Direct Ltd (MCD) giving an estimate
of costs from 6 May 2005 to the
end of the
anticipated four - day
trial which was due to start on 7 July 2005.